
SGInnovate
32 Carpenter Street, Singapore, Central Singapore, 059911
Overview
At SGInnovate, our mission is to help entrepreneurial scientists build Deep Tech startups. The world has hard problems to solve, and hard-tech answers are needed. We help entrepreneurs who want to solve hard problems build companies. We believe Singapore has the resources and capabilities to tackle hard problems that matter to people around the world. SGInnovate has been established to help ambitious and capable people to build 'technology-intensive' products borne out of science research. Our commitment is to use the full power of the Singapore ecosystem to achieve this mission.
- Total investments
- 37
- Lead investments
- 5
- Investments · 12mo
- 6
- Active investors
- 4
Sector focus
- AgTech
- Artificial Intelligence (AI)
- Autonomous Vehicles
- Government
- Medical Device
- Quantum Computing
- Venture Capital
Investment portfolio
- pQCee
Led · Seed · Jul 2026
pQCee develops practical and interoperable post-quantum cryptographic software aimed at protecting enterprise data from future quantum threats. The company emphasizes solutions that help organizations comply with emerging global security regulations. Headquartered and founded in Singapore, pQCee focuses on defending against harvest-now-decrypt-later attacks. Financially, it has just completed a $3.9 million seed round — its second institutional financing. pQCee plans to use the new funding to grow its Singapore workforce and expand its market reach across Asia, with accelerated entry plans for the U.S., Europe, and the Middle East.
- H3 Zoom
Participated · Series A · Jun 2026
Founded in 2016, H3 Zoom develops AI-powered inspection and asset-intelligence software, including Façade Inspector and Interior Inspector products, to help asset owners, facility managers, contractors and infrastructure operators move from manual inspections to data-driven, standards-aligned workflows. Its platform combines proprietary AI models, computer vision, drones and robotics-enabled data capture with inspection workflow automation, and has been deployed across high-rise buildings, commercial properties, institutional assets, transport-related infrastructure and public-sector environments in Singapore, Japan, Hong Kong SAR and Southeast Asia. The company plans to fast-track its AI roadmap—including an AI Engineering Co-Pilot, multimodal inspection workflows (360° imagery and voice notes), enterprise-grade APIs and robotics-assisted inspection capabilities—and to deepen enterprise integrations. H3 Zoom intends to scale its software and Service-as-Software offerings across Japan, Hong Kong SAR, Singapore and Southeast Asia, supported by the recent Series A funding that will accelerate product development, engineering capacity and go-to-market execution.
- Clearbot
Participated · Series A · Jun 2026
Clear Robotics develops integrated, all-electric unmanned surface vessels (USVs) and commercial retrofit solutions for autonomous maritime operations. The company operates a fleet of 26 AI-optimized USVs that perform tasks such as pollution recovery and marine surveillance, and it is developing advanced AI-driven surveying capabilities. Clear Robotics plans to scale its fleet across Southeast Asia, India and the Middle East and to build larger unmanned vessels while advancing automated port surveying R&D. It also focuses on scaling proprietary retrofit technology to prepare vessels for open-ocean operations. The company was founded in 2020 and has expanded into markets including Singapore, Malaysia and the Philippines, and has received industry recognition through awards like the Pier71 Smart Port Challenge and the Captain’s Table.
- Brano Therapeutics
Participated · Seed · May 2026
Brano Therapeutics is developing small-molecule therapies that target a metabolic abnormality implicated in heart failure with preserved ejection fraction (HFpEF). Its research is based on discoveries by Duke-NUS scientists and collaborators such as the University of Cincinnati, which suggest impaired nutrient processing in the heart contributes to disease progression. Preclinical studies reportedly show a compound can help restore metabolic regulation, reduce heart stiffness, and improve function. The company has a licensing agreement with Duke-NUS to advance these discoveries toward clinical application. Brano plans to develop new compounds and move its lead therapies into clinical trials by 2029. Financially, the company completed a $6.8 million seed round to fund these development activities.
- Vycarb
Participated · Seed · Oct 2025
Vycarb develops a carbon neutralization and measurement system that converts CO₂ into stable dissolved bicarbonate (HCO₃⁻), allowing safe, low-cost, and verifiable carbon capture directly at the emission source. The platform leverages ocean-based chemistry combined with real-time sensors to quantify and monitor captured carbon. By turning CO₂ into bicarbonate, the company provides permanent storage without the need for geological sequestration. Vycarb positions its solution as both scalable and measurable, addressing critical requirements for carbon management in heavy-emitting industries. The company plans to use recently raised capital to accelerate the commercialization of its water-based carbon storage technology, indicating an upcoming push toward market deployment and customer acquisition. While no revenue or user metrics were disclosed, the seed financing represents its first publicly reported round and supports continued technology development and early sales.